![]() |
市場調查報告書
商品編碼
2092249
獸醫病患監測設備市場-全球市場預測(2026-2032年)Veterinary Patient Monitoring Equipment Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,獸醫病患監測設備市場將成長至 1,091,670,000 美元,複合年成長率為 6.03%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 7.2456億美元 |
| 預計年份:2026年 | 760,990,000 美元 |
| 預測年份 2032 | 1,091,670,000 美元 |
| 複合年成長率 (%) | 6.03% |
獸醫病患監測設備已成為現代動物醫學的重要組成部分,可支援在手術、急診、重症監護、復健和慢性病管理中對生命徵象進行即時評估。此類別包括多參數監視器、心電圖系統、脈搏血氧飽和度分析儀、二氧化碳血壓計儀、二氧化碳測量儀、體溫計、麻醉監控器和連網穿戴設備,所有這些設備均廣泛應用於寵物醫院、專科診所、大學獸醫中心、畜牧場和研究機構。寵物照護日益醫療化、人們對麻醉安全性的期望不斷提高、先進診斷技術的廣泛應用以及人們越來越認知到持續監測是早期發現患者病情惡化的臨床安全保障,這些因素共同推動了該類設備的需求成長。在生產動物的健康管理中,監護技術支援福利監測、疾病監測以及以生產力為中心的照護模式。隨著獸醫實踐向循證工作流程轉變,準確性、互通性、易用性、應對力、感染控制設計以及與電子健康記錄的整合在設備選擇中變得日益重要。因此,該行業正從獨立的監測設備發展成為一個互聯的生態系統,從而在獸醫學的各個方面改善臨床決策、營運效率和護理連續性。
在獸醫病患監測設備領域,結構性轉變正在發生,從間歇性測量轉向利用數據進行連續觀察。越來越多的診所開始優先採用多參數平台,這些平台將心電圖 (ECG)、血氧飽和度 (SpO2)、非侵入性血壓、吐氣末二氧化碳濃度 (ETCO2)、體溫和呼吸參數整合到單一工作流程中,從而減輕手動記錄的負擔,並支持在麻醉和重症監護期間進行快速乾預。第二個重大轉變是攜帶式和無線監護設備的興起,提高了治療室、現場護理、馬科診療、動物收容所和移動牲畜獸醫服務的移動性。第三,獸醫團隊正在強調設備設計應考慮物種和品種差異,包括小型伴侶動物、短頭犬品種、外來動物、馬匹和大型動物。第四,連接性正成為一個差異化因素,診所需要能夠將監護數據與臨床資訊管理平台和遠端查看功能連接起來的系統。最後,採購標準不再僅限於設備購置成本,而是擴展到臨床可靠性、員工培訓需求、售後服務、校準需求、網路安全以及長期可用性等方面。這些變化正在創造一個更成熟的採購環境,獸醫機構不再僅僅將監測設備視為輔助工具,而是將其視為對核心臨床基礎設施的投資。
人工智慧 (AI) 正在透過增強我們獲取、解讀和回應生理訊號的方式,變革獸醫學中的病患監測。 AI 驅動的分析能夠輔助識別連續心電圖、血氧飽和度、呼吸頻率、呼氣末二氧化碳、血壓、體溫和活動數據中的模式,幫助臨床醫生識別那些難以透過間歇性人工檢查發現的早期預警訊號。在麻醉監測中,演算法警報可以透過識別低通氣、脫氧、低血壓、心律不整或延遲甦醒等異常趨勢來加強監測。在遠端和穿戴式監測中,AI 可以消除運動偽影,區分具有臨床意義的波動和噪聲,並支持對患有心臟、呼吸、內分泌和術後疾病的患者進行時間序列追蹤。這些累積效應在獸醫領域尤其重要,因為由於人員短缺和病例日益複雜,直接觀察時間往往有限。然而,AI 的應用需要針對不同物種、體型、毛髮類型、性情和臨床情況進行嚴格的檢驗。產業領導者必須應對資料品質、可解釋性、偏見、隱私、網路安全和獸醫課責等挑戰,才能確保人工智慧真正發揮臨床決策支援的作用,而非自主診斷。最有價值的提案將融合可靠的感測器、透明的演算法、基於證據的閾值以及與獸醫工作流程的無縫整合。
在亞太地區,受都市區伴侶動物數量不斷成長、畜牧健康計劃不斷擴大以及獸醫教育和專科醫療服務投入增加的推動,獸醫學正在快速現代化。中國、印度、日本、韓國、澳洲和東南亞國協正在推動麻醉監控器、攜帶式生命徵象監測系統和連網型設備設備在小型動物診所和綜合診所中的廣泛應用。在北美,由於寵物醫療費用支出穩定、專科和急診獸醫服務普及,以及臨床上高度重視麻醉安全和重症監護方案,獸醫學中的病患監測仍然非常先進。在美國和加拿大,連網監護技術與臨床工作流程和轉診醫院營運的整合也值得關注。在拉丁美洲,隨著巴西和墨西哥私立動物醫院的擴張,連網監護技術的應用也在不斷推進,儘管在農業地區,畜牧健康管理仍然是其主要應用領域。在歐洲,由於獸醫護理的高標準、動物福利法規以及完善的伴侶動物醫療保健基礎設施,市場需求已經成熟。多參數監測系統和手術監測系統在德國、英國、法國、義大利和西班牙的應用尤其廣泛。在中東,高階伴侶動物醫療保健、馬匹醫療保健、獵鷹相關獸醫服務以及海灣合作理事會(GCC)國家醫院基礎設施的擴建推動了該領域的選擇性成長。非洲的情況則較為複雜,相關應用主要集中在都市區伴侶動物診所、學術機構、野生動物醫療保健和牲畜健康管理舉措,而價格、培訓和維護的可及性以及可靠的供應鏈仍然是影響設備普及率的關鍵因素。
在東協地區,寵物數量的成長、都市區獸醫院的發展以及畜牧業健康日益受到重視,都催生了對價格合理、便攜易維護的監測系統的需求,進一步提升了獸醫病患監測設備的重要性。海灣合作理事會(GCC)地區以對高階獸醫院、馬匹護理、伴侶動物服務和專業動物醫療設施的投資為特徵,滿足了對麻醉監測、重症監護監測和先進診斷流程的需求。歐盟受益於統一的監管要求、高標準的動物福利以及完善的獸醫教育體系,這些因素共同促進了在伴侶動物和畜牧業領域使用可靠、檢驗且可互通的監測技術。金磚國家擁有多元化的商業機遇,這些國家擁有大規模的伴侶動物數量、主要的畜牧業、不斷擴展的獸醫服務網路以及對本地可維護醫療設備日益成長的需求。中國、印度和巴西在規模上尤其重要,而南非和俄羅斯的需求則涵蓋伴侶動物、牲畜和機構等多個領域。七國集團(G7)市場的特點是獸醫基礎設施成熟、臨床技術水平高,以及互聯監測、多參數系統和遠端審查功能的日益普及。北約成員國雖然並非商業集團,但其獸醫市場收入普遍較高,擁有先進的動物健康基礎設施和嚴格的監管,因此對設備的可靠性、網路安全、數據管治和強大的服務支援提出了高所得的要求。
美國在臨床技術進步方面處於主導,多參數監測廣泛應用於急診、專科、外科和全科診療。加拿大同樣重視麻醉安全、伴侶動物照護以及當地綜合診療的需求。在墨西哥,隨著私人獸醫服務和畜牧健康計畫的擴展,多參數監測的應用正在逐步普及;而在巴西,大規模的伴侶動物市場以及農業對動物健康技術的巨大需求正在推動其應用。在歐洲,英國透過其專科轉診網路和對寵物保險的高度重視,支援先進的監測技術。德國強調技術品質、臨床可靠性和系統化的獸醫護理。法國則將多參數監測應用於伴侶動物和畜牧業領域。在俄羅斯,從都市區獸醫護理到大型動物健康管理,多參數監測的需求都在成長,但採購趨勢可能受到供應狀況的影響。在義大利和西班牙,伴侶動物診所和外科手術機構的多參數監測應用正在穩步推進。在亞太地區,中國正在擴大獸醫服務基礎設施,並在主要城市推行互聯醫療;印度的發展動力源於伴侶動物診所的成長、乳牛和牲畜的健康需求,以及對經濟實惠的攜帶式設備的需求。日本在臨床精準度和老年伴侶動物照護方面展現出高標準,而澳洲則將先進的伴侶動物醫學與牲畜和馬匹的應用相結合。韓國的特點是擁有先進的都市區寵物醫療、專業診所,並且對數位化獸醫技術接受度高。
產業領導者應優先考慮經過臨床檢驗、物種適應性強的監測平台,這些平台能夠針對不同體型、品種和飼養環境的動物提供精準的測量數據。產品策略應強調多參數整合、直覺的介面、耐用的結構、電池性能、可自訂的警報功能以及與獸醫軟體的兼容性。製造商和經銷商應投資於培訓項目,幫助獸醫團隊解讀監測數據、減少警報疲勞、管理麻醉風險並正確維護設備。開發互聯且基於人工智慧的系統需要強大的資料管治、網路安全措施、透明的分析以及基於實證醫學的臨床檢驗。在新興市場,模組化產品配置、靈活的服務模式和現場維護支援有助於促進產品推廣,同時解決成本和運作的顧慮。在成熟市場,差異化應側重於互通性、遠端監測、高精度感測器、自動化記錄以及術後和慢性病護理的連續性。在所有地區,行業領導者必須使設備開發與動物福利標準、獸醫人員的效率以及日益成長的期望保持一致,即病患監測應該是連續的、實用的,並融入更廣泛的臨床決策中。
本執行摘要採用系統的二手研究方法編寫,重點關注來自獸醫臨床指南、動物衛生機構、監管機構、同行評審的獸醫文獻、獸醫專業協會、學術出版物和產品類型的檢驗且公開的資訊。分析整合了獸醫麻醉安全、重症監護監測、伴侶動物醫療保健趨勢、牲畜健康管理、數位醫療應用以及區域獸醫醫療保健基礎設施發展等方面的證據。研究結果依技術相關性、臨床應用、地理趨勢和最終用戶需求進行組織,未使用市場估算、市場規模、市場佔有率或預測數據。調查方法強調跨可信資訊來源進行檢驗驗證,以識別醫療設備應用、工作流程轉型、人工智慧整合和區域需求促進因素的一致模式。定性檢驗比較了伴侶動物、馬科動物、異寵、牲畜、學術機構和急診醫療環境中的臨床應用案例。最終形成了一份基於證據的概述,旨在為獸醫病患監測設備行業的策略規劃、產品定位和決策提供支援。
獸醫病患監測設備正從輔助角色轉變為安全、數據驅動型動物醫療保健的核心功能。該行業成長最強勁的領域包括連續多參數監測、可攜式無線系統、人工智慧訊號解讀以及與獸醫臨床工作流程的無縫整合。不同地區的部署模式有所不同:成熟市場優先考慮互通性、專科醫療和先進的監測方案,而新興市場則優先考慮經濟性、便攜性、易於維護性和培訓。在伴侶動物、家畜、馬匹和專科醫療領域,監護設備的核心價值在於其能夠提高臨床意識、支持及時干預、降低麻醉和恢復期間的風險並改善患者預後。擁有成熟技術、易用性、互聯資料基礎設施和負責任的人工智慧管治的行業相關人員將更有能力滿足獸醫學不斷變化的需求。隨著動物健康管理不斷發展,以適應更高的福利標準、精準醫療和營運效率,病患監測設備仍將是獸醫學的基礎技術。
The Veterinary Patient Monitoring Equipment Market is projected to grow by USD 1,091.67 million at a CAGR of 6.03% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 724.56 million |
| Estimated Year [2026] | USD 760.99 million |
| Forecast Year [2032] | USD 1,091.67 million |
| CAGR (%) | 6.03% |
Veterinary patient monitoring equipment has become a critical part of modern animal care, supporting real-time assessment of vital parameters during surgery, emergency treatment, intensive care, recovery, and chronic disease management. The category includes multiparameter monitors, electrocardiography systems, pulse oximeters, capnography devices, blood pressure monitors, temperature monitors, anesthesia monitors, respiratory monitors, and connected wearable devices used across companion animal hospitals, specialty clinics, university veterinary centers, livestock operations, and research settings. Demand is being shaped by the rising medicalization of pet care, higher expectations for anesthesia safety, increased use of advanced diagnostics, and wider recognition of continuous monitoring as a clinical safeguard for early deterioration detection. In production animal health, monitoring technologies are also supporting welfare oversight, disease surveillance, and productivity-focused care models. As veterinary practices move toward evidence-based workflows, equipment selection is increasingly influenced by accuracy, interoperability, ease of use, species-specific parameter adaptability, infection-control design, and integration with electronic medical records. The industry is therefore evolving from standalone monitoring devices toward connected ecosystems that improve clinical decision-making, operational efficiency, and continuity of care across veterinary settings.
The veterinary patient monitoring equipment landscape is undergoing a structural shift from episodic measurement to continuous, data-enabled observation. Clinics are increasingly prioritizing multiparameter platforms that consolidate ECG, SpO2, noninvasive blood pressure, end-tidal CO2, temperature, and respiratory metrics in a single workflow, reducing manual documentation burden and supporting faster intervention during anesthesia and critical care. A second major shift is the rise of portable and wireless monitoring, which is improving mobility in treatment rooms, field care, equine medicine, shelter medicine, and ambulatory livestock services. Third, veterinary teams are emphasizing device designs that account for species and breed variability, including small companion animals, brachycephalic breeds, exotics, equine patients, and large animals. Fourth, connectivity is becoming a differentiator, with practices seeking systems that link monitoring data to practice information management platforms and remote review capabilities. Finally, purchasing criteria are moving beyond device acquisition cost toward clinical reliability, staff training requirements, service support, calibration needs, cybersecurity, and long-term usability. These shifts are creating a more sophisticated procurement environment in which veterinary care providers evaluate monitoring equipment as a core clinical infrastructure investment rather than an auxiliary tool.
Artificial intelligence is reshaping veterinary patient monitoring by enhancing how physiologic signals are captured, interpreted, and acted upon. AI-enabled analytics can support pattern recognition across continuous ECG, oxygen saturation, respiratory rate, capnography, blood pressure, temperature, and activity data, helping clinicians identify early warning signs that may be difficult to detect through intermittent manual checks. In anesthesia monitoring, algorithm-assisted alerts can improve vigilance by identifying abnormal trends such as hypoventilation, desaturation, hypotension, arrhythmia, or delayed recovery indicators. In remote and wearable monitoring, AI can help filter motion artifacts, distinguish clinically meaningful variation from noise, and support longitudinal tracking for cardiac, respiratory, endocrine, and post-operative patients. The cumulative impact is especially relevant for high-workload veterinary environments where staff shortages and increasing caseload complexity can constrain direct observation time. However, AI adoption also requires rigorous validation across species, body sizes, coat types, temperaments, and clinical contexts. Industry leaders must address data quality, explainability, bias, privacy, cybersecurity, and veterinary accountability to ensure that AI functions as clinical decision support rather than autonomous diagnosis. The strongest value proposition will come from systems that combine reliable sensors, transparent algorithms, evidence-based thresholds, and seamless integration into veterinary workflows.
Asia-Pacific is experiencing rapid modernization of veterinary care, supported by expanding companion animal ownership in urban centers, growing livestock health programs, and increased investment in veterinary education and specialty services. China, India, Japan, South Korea, Australia, and ASEAN economies are contributing to broader adoption of anesthesia monitors, portable vital signs systems, and connected devices across small animal and mixed-practice settings. North America remains highly advanced in veterinary patient monitoring adoption due to established companion animal healthcare spending, widespread specialty and emergency veterinary services, and strong clinical emphasis on anesthesia safety and critical care protocols. The United States and Canada are also notable for the integration of connected monitoring into practice management workflows and referral hospital operations. Latin America shows increasing uptake as private veterinary clinics expand in Brazil and Mexico, while livestock health management remains a key use case across agricultural regions. Europe demonstrates mature demand driven by high veterinary care standards, animal welfare regulation, and strong companion animal medical infrastructure, with Germany, the United Kingdom, France, Italy, and Spain supporting adoption of multiparameter and surgical monitoring systems. The Middle East is seeing selective growth through premium companion animal care, equine medicine, falconry-related veterinary services, and expanding hospital infrastructure in GCC countries. Africa presents a varied landscape, with adoption concentrated in urban companion animal clinics, academic institutions, wildlife medicine, and livestock health initiatives, while affordability, training, maintenance access, and supply chain reliability continue to influence equipment penetration.
ASEAN is becoming increasingly relevant for veterinary patient monitoring equipment as rising pet ownership, urban veterinary clinic development, and livestock health priorities create demand for affordable, portable, and easy-to-maintain monitoring systems. The GCC is distinguished by investments in premium veterinary hospitals, equine care, companion animal services, and specialized animal health facilities, supporting demand for anesthesia monitoring, intensive care monitoring, and advanced diagnostic-adjacent workflows. The European Union benefits from harmonized regulatory expectations, high animal welfare standards, and well-developed veterinary education systems, which collectively support the use of reliable, validated, and interoperable monitoring technologies across companion animal and livestock settings. BRICS countries represent a diverse opportunity profile, combining large companion animal populations, major livestock industries, expanding veterinary service networks, and increasing interest in locally serviceable medical equipment; China, India, and Brazil are particularly important for scale, while South Africa and Russia contribute through mixed companion animal, livestock, and institutional demand. G7 markets are characterized by mature veterinary infrastructure, high clinical specialization, and greater adoption of connected monitoring, multiparameter systems, and remote review capabilities. NATO member countries, while not a commercial bloc, include many high-income veterinary markets with advanced animal health infrastructure and regulatory rigor, creating demand for equipment reliability, cybersecurity, data governance, and robust service support.
The United States leads in clinical sophistication, with strong use of multiparameter monitoring in emergency, specialty, surgical, and general practice settings, while Canada shows similar emphasis on anesthesia safety, companion animal care, and rural mixed-practice needs. Mexico is seeing growing adoption through expanding private veterinary services and livestock health programs, while Brazil combines a large companion animal base with significant agricultural demand for animal health technologies. In Europe, the United Kingdom supports advanced monitoring through specialty referral networks and high pet insurance awareness; Germany emphasizes engineering quality, clinical reliability, and structured veterinary care; France combines companion animal and livestock applications; Russia presents demand across urban veterinary care and large animal health, though procurement dynamics can be affected by supply conditions; Italy and Spain show steady adoption in companion animal clinics and surgical settings. In Asia-Pacific, China is expanding veterinary service capacity and connected care adoption in major cities, while India is driven by companion animal clinic growth, dairy and livestock health needs, and demand for cost-effective portable equipment. Japan demonstrates high standards for clinical precision and aging companion animal care, Australia combines sophisticated companion animal medicine with livestock and equine applications, and South Korea is marked by advanced urban pet healthcare, specialty clinics, and receptiveness to digital veterinary technologies.
Industry leaders should prioritize clinically validated, species-adaptable monitoring platforms that deliver accurate readings across diverse animal sizes, breeds, and care environments. Product strategies should emphasize multiparameter integration, intuitive interfaces, durable construction, battery performance, alarm customization, and compatibility with veterinary workflow software. Manufacturers and distributors should invest in training programs that help veterinary teams interpret monitoring data, reduce alarm fatigue, manage anesthesia risk, and maintain equipment properly. Connected and AI-enabled systems should be developed with strong data governance, cybersecurity safeguards, transparent analytics, and evidence-based clinical validation. For emerging markets, modular product configurations, flexible service models, and local maintenance support can improve adoption while addressing cost and uptime concerns. For mature markets, differentiation should focus on interoperability, remote monitoring, high-fidelity sensors, automated documentation, and post-operative or chronic-care continuity. Across all regions, leaders should align device development with animal welfare standards, veterinary staff efficiency, and the growing expectation that patient monitoring should be continuous, actionable, and integrated into broader clinical decision-making.
This executive summary is developed using a structured secondary research approach focused on verified and publicly available information from veterinary clinical guidelines, animal health authorities, regulatory bodies, peer-reviewed veterinary medicine literature, professional veterinary associations, academic publications, and product category documentation. The analysis synthesizes evidence on veterinary anesthesia safety, critical care monitoring, companion animal healthcare trends, livestock health management, digital health adoption, and regional veterinary infrastructure development. Insights are organized by technology relevance, clinical application, geographic dynamics, and end-user requirements without using market estimation, market sizing, market share, or forecasting. The methodology emphasizes triangulation across credible sources to identify consistent patterns in device adoption, workflow transformation, AI integration, and regional demand drivers. Qualitative validation is applied by comparing clinical use cases across companion animal, equine, exotic, livestock, academic, and emergency care settings. The result is an evidence-oriented overview designed to support strategic planning, product positioning, and decision-making in the veterinary patient monitoring equipment industry.
Veterinary patient monitoring equipment is moving from a supportive role to a central function in safe, data-driven animal care. The strongest industry momentum is linked to continuous multiparameter monitoring, portable and wireless systems, AI-assisted signal interpretation, and seamless integration with veterinary clinical workflows. Regional adoption patterns vary, with mature markets emphasizing interoperability, specialty care, and advanced monitoring protocols, while emerging markets prioritize affordability, portability, serviceability, and training. Across companion animal, livestock, equine, and specialty settings, the core value of monitoring equipment is its ability to improve clinical awareness, support timely intervention, reduce anesthesia and recovery risk, and strengthen patient outcomes. Industry participants that combine validated technology, practical usability, connected data infrastructure, and responsible AI governance will be best positioned to meet evolving veterinary care expectations. As animal health continues to align with higher standards of welfare, precision care, and operational efficiency, patient monitoring equipment will remain a foundational technology category in veterinary medicine.